• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同种异体反应性作为高亲和力肽特异性人细胞毒性T淋巴细胞的一个来源。

Alloreactivity as a source of high avidity peptide-specific human CTL.

作者信息

Münz C, Obst R, Osen W, Stevanović S, Rammensee H G

机构信息

Department of Immunology, Institute for Cell Biology, University of Tübingen, Germany.

出版信息

J Immunol. 1999 Jan 1;162(1):25-34.

PMID:9886366
Abstract

PBL from HLA-A2- or HLA-A3- donors were stimulated with synthetic peptide libraries fitting HLA-A2 or HLA-A3 motifs and presented on HLA-A2- or HLA-A3-expressing TAP- cells. Peptide library-specific allorestricted CTL were found to constitute up to half the alloreactive CTL response and occurred at twofold lower frequency than autologous peptide library-specific CTL. This indicates that positive selection by one particular MHC class I molecule is not absolutely essential for the generation of CTL restricted to the same molecule. However, positive selection increases their frequency. The CTL obtained differed greatly both with respect to peptide dependency and peptide specificity. Determination of the peptide avidity for one representative CTL clone, 10F4, proved that the method described here allows the stimulation of high avidity cytotoxic T cells. This approach involving in vitro stimulation of T cells restricted toward a MHC molecule that was not present during their negative selection might therefore offer the possibility of isolating CTL against self and foreign peptides with varying avidities. Such T cells might indeed be useful for tumor immunotherapy.

摘要

来自HLA - A2或HLA - A3供体的外周血淋巴细胞(PBL)用符合HLA - A2或HLA - A3基序的合成肽库进行刺激,并呈递给表达HLA - A2或HLA - A3的TAP缺陷细胞。发现肽库特异性同种异体限制性细胞毒性T淋巴细胞(CTL)构成了高达一半的同种异体反应性CTL应答,且其出现频率比自体肽库特异性CTL低两倍。这表明由一种特定的I类主要组织相容性复合体(MHC)分子进行的阳性选择对于产生受同一分子限制的CTL并非绝对必要。然而,阳性选择会增加它们的频率。所获得的CTL在肽依赖性和肽特异性方面差异很大。对一个代表性的CTL克隆10F4的肽亲和力测定证明,此处描述的方法能够刺激高亲和力的细胞毒性T细胞。因此,这种涉及体外刺激在阴性选择期间不存在的针对MHC分子的T细胞的方法,可能提供分离针对具有不同亲和力的自身和外源肽的CTL的可能性。这样的T细胞可能确实对肿瘤免疫治疗有用。

相似文献

1
Alloreactivity as a source of high avidity peptide-specific human CTL.同种异体反应性作为高亲和力肽特异性人细胞毒性T淋巴细胞的一个来源。
J Immunol. 1999 Jan 1;162(1):25-34.
2
Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL.
J Immunol. 1995 Apr 15;154(8):3880-7.
3
Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide.利用前列腺特异性抗原(PSA)寡表位肽产生针对前列腺特异性抗原的人细胞溶解T淋巴细胞系。
J Immunol. 1998 Sep 15;161(6):3186-94.
4
A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.通过用负载表位肽的自体树突状细胞和低剂量白细胞介素-2体外刺激源自前列腺癌转移灶的肿瘤浸润淋巴细胞所诱导的甲状旁腺激素相关蛋白(PTH-rP)特异性细胞毒性T细胞反应。
Br J Cancer. 2001 Nov 30;85(11):1722-30. doi: 10.1054/bjoc.2001.2136.
5
Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.使用肽-MHC四聚体从异质群体中分离高亲和力黑色素瘤反应性CTL。
J Immunol. 1999 Feb 15;162(4):2227-34.
6
707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.被人类抗体识别的707-AP肽可诱导人白细胞抗原A2限制性细胞毒性T淋巴细胞杀伤黑色素瘤。
Clin Cancer Res. 1997 Aug;3(8):1363-70.
7
Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.通过用肽脉冲树突状细胞进行初次体外免疫来鉴定癌胚抗原和HER-2/neu的HLA-A3限制性细胞毒性T淋巴细胞表位。
Cancer Res. 1999 Jan 15;59(2):431-5.
8
Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.针对源自野生型p53的HLA - A24限制性表位肽产生细胞毒性T细胞反应。
Br J Cancer. 2001 Apr 20;84(8):1052-7. doi: 10.1054/bjoc.2000.1715.
9
Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.卵巢肿瘤抗原角质层糜蛋白酶中免疫原性区域的定义。
Clin Cancer Res. 2005 May 1;11(9):3446-54. doi: 10.1158/1078-0432.CCR-04-2043.
10
Identification and characterization of a human agonist cytotoxic T-lymphocyte epitope of human prostate-specific antigen.人前列腺特异性抗原的人激动性细胞毒性T淋巴细胞表位的鉴定与表征
Clin Cancer Res. 2002 Jan;8(1):41-53.

引用本文的文献

1
Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+ T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor.非突变核仁磷酸蛋白 1 可被 HLA 单倍体相合供者造血干细胞移植后的 AML 患者 CD8+ T 淋巴细胞识别。
Curr Oncol. 2022 Apr 20;29(5):2928-2934. doi: 10.3390/curroncol29050239.
2
Empirical and Rational Design of T Cell Receptor-Based Immunotherapies.基于 T 细胞受体的免疫疗法的经验设计与理性设计。
Front Immunol. 2021 Jan 25;11:585385. doi: 10.3389/fimmu.2020.585385. eCollection 2020.
3
Allo-reactive T cells for the treatment of hematological malignancies.
用于治疗血液系统恶性肿瘤的同种反应性T细胞。
Mol Oncol. 2015 Dec;9(10):1894-903. doi: 10.1016/j.molonc.2015.10.014. Epub 2015 Oct 24.
4
MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy.MHC 多聚体引导和细胞培养独立的单细胞功能 T 细胞受体分离技术促进了免疫治疗中 TCR 的鉴定。
PLoS One. 2013 Apr 26;8(4):e61384. doi: 10.1371/journal.pone.0061384. Print 2013.
5
A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro.在体外,同种异体抗原和名义抗原诱导的 CD8+ T 细胞反应中的肽交叉反应具有相似性。
Immunogenetics. 2013 Mar;65(3):173-84. doi: 10.1007/s00251-012-0668-3. Epub 2012 Dec 12.
6
Use of tumour-responsive T cells as cancer treatment.使用肿瘤反应性T细胞进行癌症治疗。
Lancet. 2009 Feb 21;373(9664):673-83. doi: 10.1016/S0140-6736(09)60404-9.
7
Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer.利用T细胞受体基因转移将病毒特异性T细胞重编程为白血病反应性T细胞。
J Exp Med. 2004 Apr 5;199(7):885-94. doi: 10.1084/jem.20031110. Epub 2004 Mar 29.
8
The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.肽在T细胞同种异体反应性中的作用由自身主要组织相容性复合体分子决定。
J Exp Med. 2000 Mar 6;191(5):805-12. doi: 10.1084/jem.191.5.805.